Chest surgery with a new single-port robot
This trial tests a new robotic system (SHURUI Single-Port) to perform chest surgery through a single small cut. It may be an option for people who need surgery for early-stage lung cancer, limited lung tumors, or a mass in the middle of the chest.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You need surgery for early-stage lung cancer, a limited lung tumor, or a mass in the middle of the chest (mediastinum).
- Your overall health is good enough for surgery (ASA grade I, II, or III).
- You have not had chest surgery before and do not have other serious health problems that would make surgery risky.
- Your BMI is under 30 (not severely obese), and you do not have a bleeding disorder or severe allergies.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new surgical robot that uses only one small opening in the chest to remove a lung segment or lobe. It aims to see if the robot is safe and effective for patients who need this type of surgery.
This study tests whether a robotic system (Medtronic Hugo) can safely help surgeons perform chest surgery with small cuts. If you need chest surgery and are in good health, you may be able to join.
This trial uses a robotic system to assist surgeons during chest and belly surgeries. It aims to see if the robot is safe and effective for procedures like hernia repair, gallbladder removal, or hysterectomy.
This trial tests a new robotic surgical tool designed to perform minimally invasive (small-cut) chest and abdominal surgery in children. The goal is to check if it is safe and works well for procedures that normally require laparoscopic (camera-guided) surgery.
This trial tests a new robotic system that lets surgeons perform laparoscopic surgery from a distance. It's for people with certain cancers needing surgery on the kidney, prostate, stomach, colon, liver, spleen, uterus, or lung.
This trial compares two minimally invasive surgeries for early-stage non-small cell lung cancer: robotic-assisted (RATS) versus video-assisted (VATS). It aims to see which approach is better for removing a lobe or part of a lobe, focusing on recovery and safety.
Hear when a new Thoracic Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.